
Applications of artificial intelligence in drug discovery for neurological diseases.
AI revolutionizes drug discovery for neurological diseases, enhancing molecule identification and treatment potential. ๐ค๐
Discover the newest research about AI innovations in ๐ง Neuroscience.
AI revolutionizes drug discovery for neurological diseases, enhancing molecule identification and treatment potential. ๐ค๐
AI-Driven H-SYSTEM Achieves 94.87% Accuracy in Hypertensive Intracerebral Hemorrhage Diagnosis ๐ง ๐
AI in healthcare boosts efficiency, especially for neurological disorders. New models enhance cost-effectiveness and access. ๐๐ง
Enhanced brain tumor detection via MRI using Berkeley wavelet transformation shows improved accuracy and efficiency. ๐ง ๐
Amphetamine may lower Parkinson’s disease risk by 41% over 6 years, according to recent AI-driven research. ๐ง ๐
Chipiron raises $17 million for portable MRI development, aiming to enhance accessibility in local care centers and clinics. ๐ฅ๐ฐ
AI and machine learning are improving stroke treatment, aiming to reduce disability and enhance patient outcomes. ๐ง ๐ก
New AI tool, MindGlide, assesses treatment effectiveness for multiple sclerosis using MRI scans. Promising advancements in patient care. ๐ง ๐ก
AI reveals distinct disability patterns in MS with identical EDSS scores, enhancing clinical assessments. ๐ค๐
Subacute Sclerosing Panencephalitis: SSPE’s global incidence, pathogenesis, and treatment options. ๐ง ๐